LPA and metabolic dysfunction-associated steatotic liver disease: We observed more new-onset NAFLD in participants with Lp(a) concentrations <3.8 nmol/L (2.3 %), in contrast to 1.5% among participants with Lp(a) concentrations between 3.8 and 189 nmol/L and 1.3% among participants with Lp(a) > 189 nmol/L respectively (Table 1).